Enovis(ENOV)

Search documents
Enovis(ENOV) - 2022 Q4 - Earnings Call Transcript
2023-02-23 20:17
Enovis Corp (NYSE:ENOV) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Derek Leckow - VP, IR Matthew Trerotola - CEO & Director Phillip Berry - CFO Conference Call Participants Vikramjeet Chopra - Wells Fargo Securities Kyle Rose - Canaccord Genuity Dane Reinhardt - Robert W. Baird & Co. Brett Fishbin - KeyBanc Capital Markets Xuyang Li - Jefferies Vijay Kumar - Evercore ISI Operator Good morning, and welcome to the Enovis Fourth Quarter and Full Year 2022 Earnings Confer ...
Enovis (ENOV) Presents At 41st Annual Healthcare Conference - Slideshow
2023-01-20 12:56
Recent Activity HSD Organic Revenue Growth Investing in Attractive Rehab/Recovery Modalities Rapidly Expanding High Growth & Margin Recon Platform • 3-5X market growth powered by Empowr3D® Knee and Taperfill® Hip Stem © 2023 Enovis Corporation 19 Expand Geographically Fill Product Line Gaps Expand Channels Apply Technology in Other Markets Enter Logical ClinicBased Adjacencies Expand along Continuum of Care Add Digital Solutions Build around Healthcare Provider Excel Win in the core Extend Build out from co ...
Enovis(ENOV) - 2022 Q3 - Earnings Call Presentation
2022-11-02 12:52
enovis. November 2, 2022 Third Quarter 2022 Financial Update © 2022 Enovis Corporation Forward-Looking Statement and Non-GAAP Disclaimer Forward-Looking Statements This presentation includes forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Enovis' plans, goals, objectives, outlook, expectations and intentions, including the an ...
Enovis(ENOV) - 2022 Q3 - Quarterly Report
2022-11-01 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number - 001-34045 Enovis Corporation | --- | --- | |----------------------------------------------------------------------------|----------------- ...
Enovis(ENOV) - 2022 Q2 - Earnings Call Transcript
2022-08-06 17:04
Enovis Corporation (NYSE:ENOV) Q2 2022 Results Conference Call August 4, 2022 8:00 AM ET Company Participants Derek Leckow - Vice President, Investor Relations Matt Trerotola - Chief Executive Officer Chris Hix - Executive Vice President & Chief Financial Officer Ben Berry - Interim Chief Financial Officer Conference Call Participants Jeff Johnson - Baird Vik Chopra - Wells Fargo Matthew Mishan - KeyBanc Jason Wittes - Loop Capital Operator Ladies and gentlemen, thank you for standing by, and welcome to the ...
Enovis(ENOV) - 2022 Q1 - Earnings Call Presentation
2022-05-12 13:02
Letter to Our Shareholders May 2022 Q1 2022 Fellow Shareholders, During the first quarter of 2022 we achieved two very important milestones: 1) we produced advanced 3D Silicon™ lithium-ion batteries for customers from our first production line for customer qualification, and 2) we announced BrakeFlow™, a breakthrough in advanced lithium-ion battery safety. This critical innovation was possible due to our unique battery architecture, and we believe it puts considerable distance between us and any competitor ...
Enovis(ENOV) - 2022 Q1 - Earnings Call Transcript
2022-05-10 18:14
Enovis Corporation (NYSE:ENOV) Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Christopher Hix - Executive Vice President & Chief Financial Officer Matthew Trerotola - Chief Executive Officer Conference Call Participants Jeff Johnson - Robert W. Baird & Co. Matthew Mishan - KeyBanc Capital Markets Vijay Kumar - Evercore ISI Josh Jennings - Cohen Operator Good day and thank you for standing by. Welcome to the Enovis First Quarter 2022 Earnings Conference Call. At this time, all ...
Enovis(ENOV) - 2022 Q4 - Earnings Call Presentation
2022-02-22 17:18
| --- | --- | --- | |--------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fourth Quarter 2021 | | | | | | | | Earnings Conference Call | | | | February 22, 2022 | | | | | | | | | | | | | | | | | | | | | | | Forward Looking Statement & Non-GAAP Disclaimer This presentation may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements ...
Enovis(ENOV) - 2021 Q4 - Earnings Call Transcript
2022-02-22 16:24
Colfax Corporation (CFX) Q4 2021 Earnings Conference Call February 22, 2022 8:00 AM ET Company Participants Matt Trerotola – President and Chief Executive Officer Shyam Kambeyanda – Executive Vice President and Chief Executive Officer (ESAB) Chris Hix – Executive Vice Preside and Chief Financial Officer Mike Macek – Vice President of Finance Conference Call Participants Scott Davis – Melius Research Chris Snyder – Union Bank of Switzerland Joseph Giordano – Cowen and Company Jeff Hammond – KeyBanc Capital M ...
Enovis(ENOV) - 2021 Q4 - Annual Report
2022-02-21 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______to_______ Commission File No. 001-34045 _________________________ COLFAX CORPORATION (Exact name of registrant as specified in its charter) D ...